NuVasive, Theken in "insert and rotate" pact:
This article was originally published in Clinica
Executive Summary
Minimally-disruptive spinal surgery specialist NuVasive has granted spinal fixation product manufacturer Theken Spine non-exclusive access to its "insert and rotate" method technology. In return for the patented method, NuVasive will receive royalty payments of an undisclosed amount from Theken. The "insert and rotate" technique separates and stabilises adjacent vertebrae by rotating a device between the two vertebrae. It is complementary to Theken's range of products for cervical, deformity and degenerative spinal products. According to Akron, Ohio-based Theken, approximately 350 surgeons performed spinal fusion procedures using the company's implants and/or biologics in 2006.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.